title: Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism.
abstract: In this study, we show that successful parathyroidectomy is followed at 1 year by a significant individual bone mineral density (BMD) gain in nearly half of normocalcemic PHPT patients with reduced bone mass. Alkaline phosphatase levels above median were identified as an independent predictor of individual BMD gain in normocalcemic PHPT patients.
  
  
  BACKGROUND
  The aims of this study were to assess bone mineral density (BMD) gains after parathyroidectomy (PTX) in normocalcemic primary hyperparathyroidism (PHPT) at the individual level and to identify predictors of BMD gain after PTX in this context.
  
  
  METHODS
  Longitudinal cohort study of 55 PHPT patients referred for low bone mass and mild abnormalities of calcium/phosphorus metabolism, and successfully treated by PTX. BMD gain at 1 year was considered significant if ≥0.030 g/cm(2) at one site or more, without any equivalent BMD loss at another site. A logistic regression analysis was performed to identify predictive factors of individual BMD gain.
  
  
  RESULTS
  Among the 55 PHPT patients included, 29 patients with hypercalcemia, 36 patients with normocalcemic PHPT, defined by normal pre-PTX serum total (albumin-corrected) calcium (tCa), including 15 patients with normal ionized calcium (iCa), were identified. At 1 year of PTX, an individual BMD gain was observed in 73.7 % of hypercalcemic, 44.4 % of normocalcemic, and 46 % of PHPT patients with both normal tCa and iCa. Site-specific BMD gains were most important at the spine and hip in all subgroups including patients with normal iCa. Alkaline phosphatase activity above median, which reflects high bone turnover, was predictive of individual BMD gain, both in the overall cohort (OR = 4.9, 95 % CI 1.3-18.9), and in the normocalcemic group: OR = 8.4, 95 % CI 1.4-56.6.
  
  
  CONCLUSIONS
  Successful PTX is followed at 1 year by a significant individual BMD gain in nearly half of normocalcemic PHPT patients with osteoporosis. ALP levels above median could contribute to the therapeutic decision in this context.
authors.affiliation: Department of Rheumatology A, Cochin Hospital, APHP, 27 rue du Faubourg Saint-Jacques, 75014, Paris, France, koumakis@hotmail.com.
authors.forename: E
authors.initials: E
authors.lastname: Koumakis
authors.forename: J-C
authors.initials: JC
authors.lastname: Souberbielle
authors.forename: J
authors.initials: J
authors.lastname: Payet
authors.forename: E
authors.initials: E
authors.lastname: Sarfati
authors.forename: D
authors.initials: D
authors.lastname: Borderie
authors.forename: A
authors.initials: A
authors.lastname: Kahan
authors.forename: C
authors.initials: C
authors.lastname: Cormier
mesh_terms: D015502:Absorptiometry, Photon / Q000379:methods; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D015519:Bone Density / Q000502:physiology*; D002118:Calcium / Q000097:blood; D005260:Female; D006621:Hip Joint / Q000503:physiopathology; D006801:Humans; D049950:Hyperparathyroidism, Primary / Q000097:blood / Q000150:complications* / Q000503:physiopathology / Q000601:surgery; D008137:Longitudinal Studies; D008159:Lumbar Vertebrae / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000097:blood / Q000209:etiology* / Q000503:physiopathology; D016105:Parathyroidectomy; D011184:Postoperative Period; D011884:Radius / Q000503:physiopathology
chemical_list: D000469:Alkaline Phosphatase; D002118:Calcium